BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1114 related articles for article (PubMed ID: 10379472)

  • 1. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury.
    Agrawal NM; Dajani EZ
    Int J Clin Pharmacol Res; 1989; 9(6):347-57. PubMed ID: 2576801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
    Yeomans ND
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-steroidal anti-inflammatory drug gastropathy: clinical results with antacids and sucralfate.
    Lazzaroni M; Sainaghi M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S48-53. PubMed ID: 10379470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of acid suppressants in prophylaxis of NSAID damage.
    Chan FK; Sung JJ
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):433-45. PubMed ID: 11403537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
    Agrawal NM; Saggioro A
    J Rheumatol Suppl; 1991 Mar; 28():15-8. PubMed ID: 1674754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ; Agrawal NM
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biochemical protective mechanisms against non-steroidal anti-inflammatory drug induced G-I mucosal damage.
    Rainsford KD
    Acta Physiol Hung; 1989; 73(2-3):261-78. PubMed ID: 2512767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid suppression therapy: where do we go from here?
    Scarpignato C; Pelosini I; Di Mario F
    Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antirheumatic drug-induced damage of the gastroduodenal mucosa: approach to prevention].
    Domschke S; Domschke W
    Internist (Berl); 1986 Oct; 27(10):630-6. PubMed ID: 2878905
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological approach to the prevention of non-steroidal anti-inflammatory drug-induced gastropathy.
    Whittle BJ
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S43-7. PubMed ID: 10379469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G; Hopkins A; Akbar FA
    Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
    Koch M
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage.
    Agrawal NM; Dajani EZ
    J Rheumatol Suppl; 1990 Feb; 20():7-11. PubMed ID: 1969964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of NSAID-induced GI mucosal injury.
    Gerritz S; Newton WP
    J Fam Pract; 1997 Feb; 44(2):130-1. PubMed ID: 9040509
    [No Abstract]   [Full Text] [Related]  

  • 19. New method of inducing intestinal lesions in rats by intraduodenal administration of aspirin.
    Nonoyama K; Nakagawa K; Amagase K; Takeuchi K; Nakamura M; Okabe S
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S15-22. PubMed ID: 20586859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prophylaxis and therapy of gastropathy caused by non-steroidal anti-inflammatory drugs].
    László A
    Orv Hetil; 2002 Jul; 143(27):1643-8. PubMed ID: 12180001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.